Walgreens Boots Alliance Inc (WBA) Receives $84.12 Consensus Price Target from Analysts

Walgreens Boots Alliance Inc (NASDAQ:WBA) has received an average rating of “Buy” from the twenty-three research firms that are presently covering the company, Marketbeat reports. Ten analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $83.88.

Several equities research analysts recently commented on WBA shares. Royal Bank of Canada restated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Friday. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $76.00 target price on the stock in a research report on Wednesday. Loop Capital set a $90.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Tuesday. ValuEngine lowered Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Finally, Mizuho set a $87.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Wednesday, January 24th.

In other news, insider Stefano Pessina purchased 98,858 shares of the business’s stock in a transaction on Monday, January 15th. The shares were acquired at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 14.80% of the stock is currently owned by corporate insiders.

A number of large investors have recently made changes to their positions in WBA. Annex Advisory Services LLC lifted its holdings in shares of Walgreens Boots Alliance by 39.9% in the second quarter. Annex Advisory Services LLC now owns 6,213 shares of the pharmacy operator’s stock valued at $487,000 after purchasing an additional 1,772 shares in the last quarter. Investment Management of Virginia LLC lifted its holdings in shares of Walgreens Boots Alliance by 5.0% in the second quarter. Investment Management of Virginia LLC now owns 25,691 shares of the pharmacy operator’s stock valued at $2,012,000 after purchasing an additional 1,231 shares in the last quarter. Boston Family Office LLC lifted its holdings in shares of Walgreens Boots Alliance by 2.0% in the second quarter. Boston Family Office LLC now owns 25,945 shares of the pharmacy operator’s stock valued at $2,032,000 after purchasing an additional 500 shares in the last quarter. State Board of Administration of Florida Retirement System lifted its holdings in shares of Walgreens Boots Alliance by 0.8% in the second quarter. State Board of Administration of Florida Retirement System now owns 1,246,723 shares of the pharmacy operator’s stock valued at $97,631,000 after purchasing an additional 9,670 shares in the last quarter. Finally, Private Vista LLC lifted its holdings in shares of Walgreens Boots Alliance by 6,403.7% in the second quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock valued at $140,000 after purchasing an additional 574,218 shares in the last quarter. Institutional investors and hedge funds own 61.57% of the company’s stock.

Shares of Walgreens Boots Alliance (NASDAQ:WBA) traded up $1.14 during mid-day trading on Wednesday, hitting $70.92. The stock had a trading volume of 4,620,000 shares, compared to its average volume of 5,980,000. The firm has a market capitalization of $71,410.00, a PE ratio of 19.59, a price-to-earnings-growth ratio of 1.17 and a beta of 1.18. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. Walgreens Boots Alliance has a 12 month low of $63.82 and a 12 month high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.01. The company had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The business’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.10 earnings per share. equities analysts forecast that Walgreens Boots Alliance will post 5.73 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, March 12th. Shareholders of record on Thursday, February 15th will be issued a $0.40 dividend. The ex-dividend date is Wednesday, February 14th. This represents a $1.60 annualized dividend and a yield of 2.26%. Walgreens Boots Alliance’s payout ratio is currently 44.20%.

Walgreens Boots Alliance declared that its Board of Directors has initiated a stock repurchase program on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its shares are undervalued.

ILLEGAL ACTIVITY NOTICE: “Walgreens Boots Alliance Inc (WBA) Receives $84.12 Consensus Price Target from Analysts” was originally published by Week Herald and is the sole property of of Week Herald. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The correct version of this piece of content can be read at https://weekherald.com/2018/02/17/walgreens-boots-alliance-inc-wba-receives-84-12-consensus-price-target-from-analysts.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply